NCT02334748
- Conditions
- Arthralgia, Arthritis, Arthritis, Juvenile, +55 more
- Locations
-
- Novartis Investigative Site Bron, France
- Novartis Investigative Site Le Kremlin-Bicêtre, France
- Novartis Investigative Site Paris, France
Clinical trial condition
Hypergammaglobulinemia
Explore clinical trials studying Hypergammaglobulinemia. Study availability and eligibility vary by location and protocol.
136 public trials
35 recruiting studies
Hypergammaglobulinemia trial results
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
NCT02492750
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Comprehensive Frailty Assessment
NCT02033928
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- The Ohio State University Hospital East Columbus, Ohio, United States
NCT00445952
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
- Locations
-
- Institut Jules Bordet Brussels, Belgium
- CHU de Grenoble - Hopital de la Tronche Grenoble, France
- German Hodgkin's Lymphoma Study Group Cologne, Germany
- Ospedale San Martino Genoa, Italy
NCT01441973
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Sharp Clinical Oncology Research San Diego, California, United States
- Yale University School Of Medicine New Haven, Connecticut, United States
- Va Connecticut Healthcare System West Haven, Connecticut, United States
- Winship Cancer Institute. Atlanta, Georgia, United States
NCT00245037
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
- Locations
-
- Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States
NCT00376922
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
NCT01884688
- Conditions
- Asymptomatic Multiple Myeloma, Blood Protein Disorders, Hematologic Diseases, +8 more
- Locations
-
- University of Arkansas for Medical Science Little Rock, Arkansas, United States
Completed
Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma
NCT01955395
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States